AIMM Therapeutics BV

AIMM Therapeutics BV is a biotech company, established in 2004 as a joint venture between Immpact and the Academic Medical Center (AMC). AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that have been isolated from individuals who have overcome such diseases or from immunized animals.

AIMM Therapeutics BV

Meibergdreef 59
1105 BA Amsterdam

Telefoon 020 – 566 2145

info@aimmtherapeutics.com